HOME › DRUGS › MIRVETUXIMAB SORAVTANSINE-GYNX
ACTIVE SUBSTANCE / INN

MIRVETUXIMAB SORAVTANSINE-GYNX

Brand name(s): ELAHERE
FDA LISTED
PRESCRIPTION
BLA761310
ACTIVE SUBSTANCE
Mirvetuximab Soravtansine-Gynx
REGULATORS
FDA
SPONSORS / MAH
IMMUNOGEN INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELAHEREBLA761310IMMUNOGEN INCPrescription

FULL INTELLIGENCE ON MIRVETUXIMAB SORAVTANSINE-GYNX

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →